chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tachycardia; Itching hives on the trunk and bilateral arms with 15 minutes; Facial Flush; This is a spontaneous report from a contactable nurse (patient). A 49-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration (Arm Right) first dose on 08Jan2021 at single dose for covid-19 immunisation.  The patient's medical history included known allergies: Bee Venom, Coconut, and Shellfish. The patient's concomitant medication included vitamin b complex (B COMPLEX [VITAMIN B COMPLEX]), metoprolol, zolpidem tartrate (AMBIEN), and dexmethylphenidate hydrochloride (FOCALIN [DEXMETHYLPHENIDATE HYDROCHLORIDE]). The patient previously took Fenofibrate and experienced allergies.  On 08Jan2021, the patient experienced Itching hives on the trunk and bilateral arms with 15 minutes, Facial Flush, Tachycardia, Elevated. The patient was treated with Benadryl. The patient went Emergency room/department or urgent care due to the events. The outcome of the events was recovered in Jan2021. Facility where the most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination and was not been tested for COVID-19 since the vaccination.  Information on the lot/batch number has been requested.
evening that vax given mom reports t103,won't eat or drink,vomiting,listless,moans,doesn't want to move,restless during noc,seems tense-stiffens up-no sz,shaky when standing;mom reported pt back to nl 2MAR AM
A couple days after my first vaccine I noticed an enlarged lymph node  near my collarbone. It got smaller over time but was still there in April, which is when I decided to get it checked by my primary care doctor.
Information has been received from a 53 year old male consumer with allergies to NSAID's who on 12/21/00 was vaccinated with ine dose of pneumococcal vaccine 23 polyvalent. It was noted that the paatient was not sure if the vaccine was pneumococcal vaccine 23 polyvalnet, he just stated "pneumonia shot". Concomitant medications include levothyroxine sodium (Synthroid), folic acid, "Lomoto", sildenafil citrate (Viagra), ascorbic acid (vitamin C0, vitamin E, calcium, cetirizine hydrochloride (Zyrtec), diphenhydramin (Benadryl), "Desoin", amcininide (Cylocort). A couple of days later the patient developed a rash under the armpits and then it started to spread to his arms and legs. The patient sought medical attention from a dermatologist. The patient had received a pneumonia shot thirteen years ago and had no side effects. On an unspecified date, the patient also experienced fever. It was reported that no serious criteria were met. This was originally reported by a physician. Additional information has been requested. FOLLOW-UP information received 10/10/02 states, " A male reported that he received an injection of Pnu-Imune-23. The following day, he developed a fever which lasted for one day. Subsequently, he developed a rash under his arm and down his side. The patient was seen by a dermatologist and treated with an unspecified antihistamine. The reporeter indicated that the rash is improving; however, it is starting to spread to his chest and stomach. CANCELLED: Follow Up information received on 07/02/01 indicated that the patient received Pneumomavax 23 vaccine on 12/21/00. This information has been to the manufacturer of Pneumovax 23."
Pt began being very confused and altered 10 days after vaccine no other cause found. No mention of vaccine in chart but pt very confused no other cause.
pt recvd vax 22AUG95 & 7SEP95 pt exp a mild prodrome & devel a varicella-like rash;no further details were provided;
Immediately following vaccine administered in left arm, Cold rushing sensation throughout the arm intense stinging and pain. Over the next few hours left arm pain became intolerable and left arm could not be lifted. One week later arm has not recovered fully.
PATIENT STATED SHE DEVELOPED SHINGLES ON 04/15/2019. DR ESCRIBED VALTREX ON 04/18/2019.
When I was 15, I realize now the CFS/ME virus must have been triggered by the Mono virus. I became severely ill which was triggered by my first kiss. I later took the DTaP of some kind for a food handlers' permit. There were many times I nearly died. My throat swelled up to where I could hardly breathe. Mom took me to a Dr. who dx'd me with mono. I got sick again at 16 when I tried to work. It happened again at 18, after I had sex the first time, and I had to have bed rest for 6 weeks. Around 20, dx'ed with "Chronic Fatigue/Epstein Barr," after I got married. At 22, nearly lost my life after childbirth. Became skinny as a rail. It was only years later, after my children with Asperger's had been victims many times, and were medicated for several years, that my son ended up in kidney failure, after Crohn's that developed after he was assaulted at school. The school covered it all up. He developed pancreatitis and was treated like a drug addict by hospital staff. My son was never a drug addict. He was so sick, and dying, and abused. I became ill from repeated trauma after that, which has now disabled me. The pain is unbelievable, yet I refuse medication, so doctors will not help me. I had to fight for dx other than "conversion disorder," which is what they tried to pin on me. Cruel. Doctors told me for years it was "all in my  head." It wasn't and isn't. It's virally-caused, and I even have photographs of myself before and after the vaccinations in 1973.
Vasculitis rash (biopsy proven), fever. Vaccines 8/5. Rash 8/7
THE DAY AFTER THE VACCINATION, THE PATIENT'S ARM WAS SWOLLEN, WARM, AND PAINFUL. SHE MADE AN APPOINTMENT WITH A NP AT HER PRIMARY CARE CLINIC AND RECEIVED A PRESCRIPTION FOR KEFLEX. NO ADDITIONAL TESTS WERE DONE.
does moderna vaccine cause lymph nodes to swell in your armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit). At the time of the report, LYMPHADENOPATHY (does moderna vaccine cause lymph nodes to swell in your armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment medication was not provided.
Pt recvd vax & 25OCT92 pt devel a rash, low grade fever, stuffy nose & drainage around the eye w/mild eye irritation; fever resolved; pt devel ear infect;
Heart issues; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart issues) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    Concurrent medical conditions included Ulcerative colitis.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 28-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CARDIAC DISORDER (Heart issues). At the time of the report, CARDIAC DISORDER (Heart issues) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality for the event of heart issues with Humira (adalimumab) was no reasonable possibility. The reporter assessed event heart issues was possibly related to Moderna Covid-19 vaccine.  No treatment details were reported.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
This case was reported by a physician and described the occurrence of hives in a subject of unspecified age and gender who was vaccinated with Influenza vaccine (manufacturer unspecified). Concurrent medical conditions included splenectomy. On an unspecified date the subject received a dose of Influenza vaccine (details unknown). At an unspecified time after vaccination with Influenza vaccine, the subject experienced hives. The physician reported that he had a "patient who developed hives from the flu vaccine". He explained that the subject needed HIBERIX as the subject was status post a splenectomy and that the "package insert states that patients should not get the HIBERIX if they are allergic to any of its ingredients". The physician stated that he did not see a list of ingredients for HIBERIX and asked if getting HIBERIX would be a problem for the subject. At the time of reporting the outcome of the event was unspecified. The physician considered the event was related to vaccination with Influenza vaccine ("hives from the flu vaccine").
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication reported.  It was reported that the data logger that caller was unable to download were for the months of Dec-2021, Jan-2022, and Feb-2022. The reporter also stated that no adverse reactions were reported by any patients. The reporter reiterated that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion.  No Treatment medication reported.
patient was given 0.2 ml of toddler dose undiluted   no adverser effects noted
gotten the 1st shingles shot but never got the 2nd one; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine (received 1st dose 5 or 6 years before).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: gotten the 1st shingles shot but never got the 2nd one). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-Mar-2023 The patient had gotten the 1st shingles shot but never got the 2nd one. The reporter asked if anyone know if they could get the 2nd one only if it had been 5-6 years since getting the 1st or would he/ she need to start the whole round of both shots again. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Client  presented to the vaccination site on 12/04/2021. The client notified PHNthat she received a second dose of Pfizer COVID vaccine on 01/08/2021 and is here for the Moderna booster. Per patient developed body aches and fever after vaccine (dose not remember time frame), she reports that symptoms lasted 8-10 hours, however the last hour of symptoms she experienced shortness of breath and chest pain. All symptoms subsided without intervention and client did not follow up with primary care provider. Patient denies underlying conditions, no known allergies and taking birth control. PHN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Moderna booster. Approval to proceed with COVID vaccine Moderna booster  was obtained from medical consult team via text message from MD, Vaccine Operations Lead . Client received COVID vaccine Moderna booster Lot# 035C21A on 12/04/2021. The client did not report any symptoms during the 30 minute observation period. PHN educated client on possible adverse reactions and when to seek medical care. The client left the vaccination site at 12:45pm, client left facility with a steady gait. VAERS and VERP completed.
Rash at vaccination site; 12/20/2008 episodes of high fever (100 - 103 degrees)with chills; Rash spread throughout body and lasted several weeks;12/25/2008 heart attack - resulted from adverse allergic reaction and stress caused by flu shot according to cardiologist 11/24/09 Medical records received for date 12/22/08. DX: allergy drug.  Pt. called MD office to state has itchy rash on various spots of body since flu shot 6 days ago. Assessment(+)raised erythematous lesions across the trunk. OV 12/26/08 DX: angina pectoris. Pt c/o chest pain, chest tightness, radiating down left arm, nausea, SOB x3 days, resolved now. Assessment: (+)fatigue, increased HR. MD note pt admitted to hosp. 12/27/08 for A-fib.
fever; Body ache; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6205) via an unspecified route of administration in the left arm on 23Mar2021 at 11:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patients medical history included allergy to iodine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EJ6202) via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and vitamin D3 (MANUFACTURER UNKNOWN); all for an unknown indication and from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient had temperature of 101.2, body ache and joint pain. The patient did not receive any treatment for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events having temperature, body ache and joint pain were unknown at the time of reporting.   No follow-up attempts are needed; No further information is expected.
Hospitalized for septic shock and in ICU for 2 days due to low blood pressure and low heart rate (February 17-22, 2022).
I first noticed it when I would walk my two miles a day. Around April 1st I couldn't make it all the way home. I was extremely fatigued more so like my legs couldn't move anymore. When I got back home I checked my pulse ox and noticed an irregular heart rate. My oxygen was fine. Then I started to notice it started to happen more frequent at random times. I went to my cardiologist and he confirmed the erratic heart rate. I am scheduled next week for tests and I have been placed on a heart monitor.
Pruritus, induration, cellulitis. Antibiotics started 6/17/16.
This spontaneous report as received from a nurse refers to an unspecified number of patients. On 08-SEP-2014 the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot #, expiration date, dose and route unspecified). No adverse symptoms reported. The temperature excursion was found to be supported by in-house stability data. This is one of several reports received from same source. Additional information has been requested.
Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A214) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and SALBUTAMOL SULFATE (INHALERIN) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location). At the time of the report, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Band aid where shot was , was located far back on shoulder, concerned shot was given in the wrong location) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details were not reported   This case was linked to MOD21-080680 (E2B Linked Report).; Sender's Comments:  MOD21-080680:Wife's case
No adverse reactions until 13 hrs later.. From then and until present time (30hrs since shot): fever 100.2-101.4 even when treated with Tylenol, three occasions of diarrhea, arm soreness and stiffness, and I have slept 13hrs out of the last 19hrs. I was forced to take the day off work and my husband has taken care of the kids and house with no help from me as I couldn?t function under these conditions.
Left arm was sore after injection, but on day 8 after receiving the vaccine my arm throbs all the time.  I have had pain in my left arm from the shoulder to the elbow for the past 5 days and it seems to get worse.  Ibuprofen and Tylenol did not seem to help much.  It is difficult to use the arm because of the pain .  I can?t sleep right now so I figured I would fill this out.
pancreatic issues; illness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown). The reporter is the parent.  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PANCREATIC DISORDER (hospitalization), outcome "unknown", described as "pancreatic issues"; ILLNESS (non-serious), outcome "unknown".  Clinical information: It was reported that the son has been dealing with pancreatic issues since his covid vaccine. He is only 16 we are currently under the care of (Hospital name withheld). Prior to this (Name withheld) was very healthy. He is trying to finish his junior year of high school. They believed his illness could be related to the vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I lost about 50% of my sense of touch in my hands (peripheral neuropathy-diagnosed) about 2 weeks after my vaccine and has not improved for about 4 months now.
cheeks, chin and marionette lines/ swelling; bruising; cheeks, chin and marionette lines/ pain; cheeks, chin and marionette lines/ pain; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 at single dose for COVID-19 immunization, started to receive hyaluronic acid, lidocaine (RESTYLANE L) from 23Mar2021 for unspecified indication. Medical history was not provided. Concomitant medications were not provided. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date at single dose for COVID-19 immunization. Patient injected to cheeks, chin and marionette lines with hyaluronic acid, lidocaine on 23Mar2021 and experienced swelling, bruising, and pain in Mar2021. Patient took Arnica, ibuprofen and applied ice; bruising resolved, other events were ongoing. Action taken with hyaluronic acid, lidocaine was unknown. Outcome of the event bruising was recovered while other events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient received 1st dose Pfizer vaccine in the outpatient pharmacy by nurse. 5 min after vaccine, patient felt faint and was nauseated. Medical alert called by outpatient pharmacy. Patient laid across the bench and feet were elevated. 1st BP 11:31 was 91/45 HR 72 sat 100%. Patient was alert but stated her head felt warm. Unable to get a glucose reading. 2nd BP 1133am 94/46 HR 77 SAT 100%. Patient was sitting and stated her heart felt like it was racing. Last BP 1138am 93/66 HR 74. Patient transported via wheelchair to the ED by ED nurse. Accompanied by mother.
This spontaneous report as received from a physician refers to a 40 days old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 16-SEP-2015, the patient was inadvertently vaccinated with a dose of VAQTA (dose, route of administration, lot # and expiration date were not reported) instead of an intended dose of RECOMBIVAX HB. No adverse effects were reported. The error occurred due to miscommunication between staff members as to which product was intended for administration. No product confusion was reported. Additional information has been requested.
Patient had swelling and redness along the entire upper arm/bicep along with pain and itchiness. Started the evening following vaccination and continuing through to the next day. Advised patient after ER visit to follow up with primary provider if symptoms do not improve within the next day or two